(lp0
S'Stocks: The Puma Biotechnology Inc  Shares Sold by Swiss National Bank Petro Global News 24 - Jan 8, 2017 Several other hedge funds have also added to or reduced their stakes in PBYI. Teacher Retirement System of Texas raised its stake in Puma Biotechnology by 13.7% in the second quarter. Teacher Retirement System of Texas now owns 3,848 shares of the&nbsp;...'
p1
aS'Puma Biotechnology Inc  Soars 11.08% on April 17 Equities.com - 12 hours ago Puma Biotechnology Inc  had a good day on the market for Monday April 17 as shares jumped 11.08% to close at $39.60. About 1.31 million shares traded hands on 8,432 trades for the day, compared with an average daily volume of 901,970 shares&nbsp;...Analyst Views And Outlook On Two Stocks: Puma Biotechnology, Inc. (PBYI ... - Post AnalystResearch Brokerage Views on Puma Biotechnology, Inc.  DSP Group ... - Sherwood Daily'
p2
aS'Puma Biotechnology Announces FDA Advisory Committee to Review Neratinib for ... Business Wire  - 21 hours ago LOS ANGELES, Calif.----Puma Biotechnology, Inc. , a biopharmaceutical company, today announced that the U.S.'
p3
aS"Why Puma Biotechnology Inc. Got Hammered Today Motley Fool - Mar 2, 2017 The potential to establish a new standard of care where patients take Herceptin and Perjeta for a year could be problematic for Puma Biotechnology because its drug candidate, neratinib, was tested after just Herceptin use, the current standard of care.Puma Biotech shares plummet 26% after Roche reports positive results for late ... - MarketWatchAphinity All But Confirms Puma's Worst Nightmare - Seeking Alpha"
p4
aS"Thursday's Biotech Insights: Aurinia Pharmaceuticals Inc , Puma ... Smarter Analyst - Mar 2, 2017 Puma Biotechnology Inc  shares lost one-quarter of their value today, after competitor Roche announced positive top-line results from the highly anticipated APHINITY trial, which explores usefulness of Perjeta in adjuvant breast cancer ...Puma Biotechnology Shares Plunge On Plans To Modify Neratinib European MAA ... - Benzinga"
p5
aS"Why Puma Biotechnology Inc. Sold Lower Today Motley Fool - Oct 19, 2016 Puma Biotechnology is looking to raise $150 million selling shares, which will dilute current shareholders. Another $22.5 million of shares could also be sold within 30 days if the underwriters want the extra shares.Puma Biotechnology Inc  Swamped by New Shares - Scibility MediaHere's What's Going On With Puma Biotech's Secondary Offering - Benzinga"
p6
aS"Why Puma Biotechnology Inc Roared Higher Today Motley Fool - Sep 20, 2016 Puma Biotechnology  was up as much as much as 15% today after announcing that the Food and Drug Administration accepted the company's marketing application for its breast cancer drug neratinib, although it's given up some of that gain&nbsp;...JP Morgan Comments on Puma Biotechnology Inc  Following NDA Acceptance - Smarter AnalystPuma Biotechnology Announces US FDA Acceptance of New Drug Application for ... - Business Wire "
p7
aS'Why Puma Biotechnology, Inc. Stock Soared 65.1% in July Motley Fool - Aug 4, 2016 What: Shares of Puma Biotechnology, Inc.  a clinical-stage biopharmaceutical company developing a cancer therapy, shot up 65.1% in July, according to data from S&amp;P Global Market Intelligence.'
p8
aS'Puma Biotech Crashes After Bad News About Its Breast Cancer Drug Benzinga - Nov 14, 2016 Puma Biotechnology Inc  shares were down a whopping 21.73 percent on about 5 times its average volume. The plunge has come after a decent bump up last week since a recent low of $34.60 reached November 4.'
p9
aS"Caligor to Support Puma Biotechnology's Expanded Access Program for PB272 ... Business Wire  - Apr 12, 2017 Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care."
p10
a.